We have heard it for years – paying for prescription medications can be the most expensive out-of-pocket healthcare expense for Americans. And, everyone at the conference knows that this has a major impact on workers’ compensation costs. With cost drivers ranging from inflation to overuse to price gouging and rogue CEOs, what does big pharma have to say? We invite Phil Walls of myMatrixx to deconstruct the issue: how did we get to this point, and what comes next? He will cover the factors at play with specialty drugs, an aging workforce, increasing generic costs, drug patents, and the impact on the workers’ compensation community. Plus, he will work through case studies of several well-known medications.
Approved for 1.25 CLE, CCMC, SHRM, and HRCI general (HR) credits.